An innovative outbreak detection program that tracks disease-causing viruses in wastewater identified the measles virus in Houston samples collected in early January 2025, before cases were reported. The team that developed the program, which includes researchers at Baylor College of Medicine, the School of Public Health at University of Texas Health Science Center—Houston, the Houston Health Department and Rice University, published their findings in the American Journal of Public Health.

Zynex (Nasdaq:NYXI) announced today that it submitted its NiCO non-invasive co-oximeter device for FDA 510(k) clearance.

Limited Release Targets Biotech Innovators with Real-Time Droplet-Based Assays to Accelerate Therapeutic Discovery

Milestone Approvals Enable European and UK Market Access for AI-Based Cardiac Arrest Prediction Tool

Revolutionary system combines ultrasonics and ultraviolet energy to destroy airborne pathogens and pollutants beyond traditional purification limits.

GE HealthCare (Nasdaq: GEHC)+
today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI system.

Tim Friede has survived hundreds of snakebites—on purpose. For nearly two decades, he let some of the world’s most dangerous snakes sink their fangs into his arms, all for science.

Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a certified lab to be tested on the same test as the doctor’s office, with the same accuracy.